6 completed, 2 not yet recruiting, 1 recruiting, 1 unknown. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 6, Not yet recruiting 2, Recruiting 1, Unknown 1, Withdrawn 1 |
Follow Urge Incontinence: new trials by email Literature Review of Urge Incontinence trials Research Report on Urge Incontinence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections Pro-Nox Nitrous Oxide/Oxygen Delivery System, Standard Care for Bladder Botox Injection, Sham Mask - Overactive Bladder, Neurogenic Bladder | Phase 4 | Not yet recruiting | TriHealth Inc. | 96 | 2026-02-01 | 2026-02-04 |
| Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women Low intensity shockwave therapy, Oral Solifenacin succinate 5 mg - Overactive Bladder (OAB), Urge Incontinence | Phase 4 | Recruiting | Mansoura University | 70 | 2025-11-11 | 2026-03-16 |
| Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections Lidocaine 2% without vessel constrictor - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Not yet recruiting | University of Louisville | 36 | 2024-12-01 | 2024-11-19 |
| Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection Single-Dose Antibiotic, Multi-Dose Antibiotic - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Completed | The Cleveland Clinic | 100 | 2022-12-06 | 2024-01-02 |
| Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial OnabotulinumtoxinA 100 UNT [Botox] - Overactive Bladder, Urinary Urge Incontinence | Phase 4 | Completed | University of California, Irvine | 116 | 2022-05-01 | 2026-02-25 |
| A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder mirabegron - Urge Incontinence, Overactive Bladder (OAB) | Phase 4 | Completed | Astellas Pharma China, Inc. | 249 | 2021-01-06 | 2024-11-15 |
| Minimizing Pain During Office Intradetrussor Botox Injection Bicarbonate protocol, Standard protocol - Overactive Bladder, Overactive Detrusor | Phase 4 | Completed | Boston Urogynecology Associates | 85 | 2020-08-15 | 2025-03-06 |
| Oral vs Intravesical Analgesia for Office Bladder Botox Injections Phenazopyridine, Lidocaine 2% Injectable Solution - Overactive Bladder Syndrome, Urge Incontinence | Phase 4 | Unknown | Women and Infants Hospital of Rhode Island | 110 | 2018-11-01 | 2020-05-29 |
| Treatment of Incontinence Without Memory Problems Mirabegron, Tolterodine Tartrate - Urge Incontinence, Urinary Incontinence, Urge | Phase 4 | Completed | University of California, San Francisco | 23 | 2016-02-01 | 2019-04-16 |
| Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder solifenacin succinate, placebo - Urinary Urge, Urge Incontinence | Phase 4 | Withdrawn | Stamford Hospital | 2008-11-01 | 2016-12-06 | |
| A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) Solifenacin succinate, Simplified bladder training - Overactive Bladder, Urinary Incontinence | Phase 4 | Completed | Astellas Pharma Inc | 643 | 2006-05-01 | 2014-09-18 |
Urinary Incontinence, Urge (11) · Urinary Bladder, Overactive (10) · Urinary Incontinence (3) · Urinary Bladder, Neurogenic (2) · Agnosia (1) · Pain (1) · Pelvic Floor Disorders (1) · Spasm (1)
Female Urogenital Diseases (11) · Female Urogenital Diseases and Pregnancy Complications (11) · Lower Urinary Tract Symptoms (11) · Male Urogenital Diseases (11) · Pathological Conditions, Signs and Symptoms (11) · Signs and Symptoms (11) · Urination Disorders (11) · Urogenital Diseases (11) · Urologic Diseases (11) · Urological Manifestations (11) · Urinary Bladder Diseases (10) · Urinary Incontinence (8) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Neurobehavioral Manifestations (1)
Lidocaine (3) · Solifenacin Succinate (3) · mirabegron (2) · AIEOP acute lymphoblastic leukemia protocol (1) · Anti-Bacterial Agents (1) · Antibiotic Prophylaxis (1) · Botulinum Toxins, Type A (1) · Nitrous Oxide (1) · Oxygen (1) · Phenazopyridine (1) · Standard of Care (1) · Tolterodine Tartrate (1) · onabotulinum toxin A (1)
Astellas Pharma China, Inc. (1) · Astellas Pharma Inc (1) · Boston Urogynecology Associates (1) · Mansoura University (1) · Stamford Hospital (1) · The Cleveland Clinic (1) · TriHealth Inc. (1) · University of California, Irvine (1) · University of California, San Francisco (1) · University of Louisville (1) · Women and Infants Hospital of Rhode Island (1)
United States (8) · Australia (1) · Belgium (1) · China (1) · Czechia (1) · Egypt (1) · France (1) · Hungary (1) · Italy (1) · Netherlands (1) · Poland (1) · Russia (1) · Spain (1) · Turkey (Türkiye) (1)
Carly Crowder, MD (1) · Emily Slopnick, MD (1) · Felicia Lane, MD (1) · Lauren E Stewart, MD (1) · Leslee Subak, MD (1) · Sean Francis, MD (1) · Taylor Brueseke, MD (1)